Get the Stockscreener App
2.74
7.43%
-0.22
After Hours:
2.74
Vivosim Labs Inc stock is traded at $2.74, with a volume of 59,600.
It is down -7.43% in the last 24 hours and down -34.61% over the past month.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
See More
Previous Close:
$2.96
Open:
$2.96
24h Volume:
59,600
Relative Volume:
0.19
Market Cap:
$7.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.18%
1M Performance:
-34.61%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.69
$2.9891
1-Week Range:
$2.69
$3.5399
52-Week Range:
$1.41
$5.30
Vivosim Labs Inc Stock (VIVS) Company Profile
Name
Vivosim Labs Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO
Compare VIVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIVS
Vivosim Labs Inc
|
2.74 | 7.70M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Vivosim Labs Inc Stock (VIVS) Latest News
How VivoSim Labs Inc. stock reacts to job market dataJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
Does VivoSim Labs Inc. show high probability of reboundWall Street Watch & Safe Swing Trade Setups - newser.com
How supply chain issues affect VivoSim Labs Inc. stockPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Can a trend reversal in VivoSim Labs Inc. lead to recoveryJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Is VivoSim Labs Inc. stock trading near support levels2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com
Can VivoSim Labs Inc. (4OR) stock deliver consistent EPS growthJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Using R and stats models for VivoSim Labs Inc. forecasting2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - newser.com
How VivoSim Labs Inc. (4OR) stock performs during market turbulence2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Is VivoSim Labs Inc. (4OR) stock a buy before earnings resultsSell Signal & Weekly Return Optimization Alerts - newser.com
Analyzing VivoSim Labs Inc. with risk reward ratio charts2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com
Combining machine learning predictions for VivoSim Labs Inc.M&A Rumor & Fast Entry Momentum Alerts - newser.com
Is VivoSim Labs Inc. (4OR) stock cheap by valuation metricsMarket Weekly Review & Growth Focused Investment Plans - newser.com
VivoSim Labs, Inc. (NASDAQ:VIVS) Short Interest Up 485.2% in September - Defense World
What drives VivoSim Labs Inc stock priceRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in
What analysts say about VivoSim Labs Inc stockValue Stock Picks & Breakthrough Stock Performance - earlytimes.in
earlytimes> 2025> VIPS Stock Analysis and ForecastFundamental Stock Analysis & Small Budget Trading Plans - earlytimes.in
What’s next for MOGO stock price2025 Sector Review & Low Risk High Win Rate Picks - newser.com
How institutional buying supports Somers Group Holdings Ltd. stockTrade Risk Assessment & Community Verified Trade Signals - newser.com
Can trapped investors hope for a rebound in Giftify Inc.CEO Change & Free Community Consensus Stock Picks - newser.com
Will Auscan Resources Inc. (J0Z) stock keep high P E multiples2025 Retail Activity & Community Verified Swing Trade Signals - newser.com
Will Westport Fuel Systems Inc. price bounce be sustainableMarket Performance Summary & Fast Exit and Entry Strategy Plans - newser.com
Will Immix Biopharma Inc. stock outperform growth indexesSwing Trade & Free Risk Controlled Daily Trade Plans - newser.com
Why Melar Acquisition Corp. I Equity Warrant stock is in analyst buy zone2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
What RSI levels show for IDT Corporation (IDC2) stockJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Why Janus Henderson U.S. Real Estate stock attracts wealthy investorsWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Vivosim Labs Inc Stock (VIVS) Financials Data
There is no financial data for Vivosim Labs Inc (VIVS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):